Regulus Therapeutics Announces Timing for Second Quarter 2021 Financial Results Webcast and Conference Call
–Company also Announces Participation in a Panel Discussion at the 2021 Wedbush PacGrow Healthcare Conference
SAN DIEGO, Aug, 3, 2021 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development…
